Provectus Pharmaceuticals Inc. Receives Patent Allowance from U.S. Patent and Trademark Office

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, has received allowance of its U.S. patent application, protecting therapeutic agents based on a novel photoactive analog of its lead photodynamic product PH-10, from the United States Patent and Trademark Office (USPTO).

Back to news